FIELD: biotechnologies.
SUBSTANCE: invention relates to biotechnology. Method for determining the ability of tuberculosis mycobacteria to growth in alveolar macrophages of patients after antituberculous therapy is offered. Method involves taking samples of lung tissue from the surgical material, obtaining ex vivo alveolar macrophage cultures from it, fixing the cells on the coverslips 12–20 hours and 5–8 days after the beggining of the culture cultivation, and staining the samples using the Ziehl-Nielsen method. Thereafter, the proportion of alveolar macrophages containing colonies of growing mycobacteria is evaluated and the indicator obtained 12–20 hours after the beginning of the cultivation is compared with the index obtained 5–8 days after the beginning of cultivation. When the proportion of alveolar macrophages containing colonies of multiplying mycobacteria increases from the total number of alveolar macrophages containing mycobacteria, the conclusion about the high ability of mycobacteria to activate reproduction in the alveolar macrophages of the patient is made by 10 % or more during cultivation. With an increase in this indicator less than 10 %, a conclusion about the average ability of mycobacteria to activate reproduction in alveolar macrophages of the patient is made. In the absence of changes in this indicator during the cultivation process or when it decreases, a conclusion is made about the low ability of mycobacteria to activate reproduction.
EFFECT: invention provides higher diagnostic accuracy of tuberculosis.
1 cl, 6 dwg, 4 ex, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCING ex vivo ALVEOLAR MACROPHAGE CULTURES OF THE OPERATIONAL MATERIAL OF PATIENTS SUFFERING PULMONARY TUBERCULOSIS AND METHOD FOR ESTIMATING VIRULENCE OF Mycobacterium tuberculosis USING THE OBTAINED ex vivo ALVEOLAR MACROPHAGE CULTURES | 2015 |
|
RU2593725C1 |
METHOD FOR ESTIMATING ANTIMYCOBACTERIAL ACTION OF ANTI-TUBERCULOSIS DRUGS USING BIOLOGICAL MATERIAL OF PATIENTS WITH PULMONARY TUBERCULOSIS | 2017 |
|
RU2677972C1 |
METHOD FOR ASSESSING THE BALANCE OF THE IMMUNE, INFLAMMATORY AND ANTI-INFLAMMATORY REACTION OF ALVEOLAR MACROPHAGES RECOVERED FROM RESECTED PARTS OF THE LUNG OF PATIENTS SUFFERING PULMONARY TUBERCULOSIS, DEPENDING ON THE DEGREE OF MYCOBACTERIUM TUBERCULOSIS MACROPHAGES INFECTION | 2019 |
|
RU2712946C1 |
STRAIN OF MYCOBACTERIUM TUBERCULOSIS BN FOR MODELLING LATENT TUBERCULOSIS INFECTION | 2021 |
|
RU2760751C1 |
METHOD FOR OBTAINING A SPECIFIC IMMUNOMODULATOR | 2021 |
|
RU2764467C1 |
METHOD OF LIFE-TIME DIAGNOSIS OF CATTLE TUBERCULOSIS | 2020 |
|
RU2738133C1 |
RECOMBINANT INFLUENZA VIRUS STRAINS EXPRESSING MYCOBACTERIAL PROTECTIVE ESAT-6 ANTIGEN AND USES THEREOF IN TUBERCULOSIS TREATMENT AND PROPHYLAXIS | 2005 |
|
RU2318872C2 |
PREPARATION BASED ON LYTIC MYCOBACTERIOPHAGE AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2691439C1 |
METHOD FOR SIMULATING KIDNEY TUBERCULOSIS | 2021 |
|
RU2776130C1 |
METHOD FOR MODELING THE DORMANT STATE OF MYCOBACTERIUM TUBERCULOSIS IN VITRO | 2018 |
|
RU2707941C1 |
Authors
Dates
2018-05-03—Published
2017-02-17—Filed